Mackenzie Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109M | Sell |
222,589
-107,077
| -32% | -$58.1M | 0.13% | 144 |
|
|
2025
Q4 | $192M | Buy |
329,666
+53,121
| +19% | +$30M | 0.23% | 100 |
|
|
2025
Q3 | $134M | Buy |
276,545
+62,790
| +29% | +$29.2M | 0.16% | 126 |
|
|
2025
Q2 | $86.7M | Sell |
213,755
-571,633
| -73% | -$239M | 0.11% | 165 |
|
|
2025
Q1 | $391M | Sell |
785,388
-118,550
| -13% | -$64.2M | 0.56% | 46 |
|
|
2024
Q4 | $470M | Sell |
903,938
-18,118
| -2% | -$9.96M | 0.64% | 40 |
|
|
2024
Q3 | $570M | Buy |
922,056
+371,197
| +67% | +$220M | 0.79% | 32 |
|
|
2024
Q2 | $305M | Sell |
550,859
-65,075
| -11% | -$37.3M | 0.45% | 59 |
|
|
2024
Q1 | $358M | Buy |
615,934
+2,004
| +0.3% | +$1.12M | 0.52% | 52 |
|
|
2023
Q4 | $326M | Sell |
613,930
-602,973
| -50% | -$292M | 0.49% | 53 |
|
|
2023
Q3 | $608M | Sell |
1,216,903
-53,424
| -4% | -$28.5M | 1.02% | 23 |
|
|
2023
Q2 | $659M | Buy |
1,270,327
+280,008
| +28% | +$151M | 1% | 25 |
|
|
2023
Q1 | $571M | Buy |
990,319
+56,336
| +6% | +$31.8M | 0.88% | 28 |
|
|
2022
Q4 | $514M | Buy |
933,983
+20,901
| +2% | +$11.1M | 0.86% | 27 |
|
|
2022
Q3 | $463M | Buy |
913,082
+168,919
| +23% | +$94.5M | 0.8% | 29 |
|
|
2022
Q2 | $404M | Buy |
744,163
+13,954
| +2% | +$7.68M | 0.65% | 34 |
|
|
2022
Q1 | $431M | Buy |
730,209
+99,052
| +16% | +$56.9M | 0.58% | 41 |
|
|
2021
Q4 | $421M | Sell |
631,157
-130,695
| -17% | -$81.6M | 0.57% | 41 |
|
|
2021
Q3 | $435M | Buy |
761,852
+32,040
| +4% | +$17.6M | 0.62% | 42 |
|
|
2021
Q2 | $368M | Sell |
729,812
-213,324
| -23% | -$101M | 0.51% | 51 |
|
|
2021
Q1 | $430M | Buy |
943,136
+629,471
| +201% | +$300M | 0.66% | 37 |
|
|
2020
Q4 | $146M | Sell |
313,665
-34,970
| -10% | -$16.4M | 0.32% | 99 |
|
|
2020
Q3 | $154M | Sell |
348,635
-63,545
| -15% | -$26.3M | 0.38% | 80 |
|
|
2020
Q2 | $149M | Buy |
412,180
+26,214
| +7% | +$8.79M | 0.4% | 68 |
|
|
2020
Q1 | $109M | Sell |
385,966
-475,675
| -55% | -$150M | 0.35% | 78 |
|
|
2019
Q4 | $280M | Buy |
861,641
+226,320
| +36% | +$68.6M | 0.69% | 42 |
|
|
2019
Q3 | $185M | Buy |
635,321
+623,859
| +5,443% | +$179M | 0.49% | 53 |
|
|
2019
Q2 | $3.37M | Sell |
11,462
-4,516
| -28% | -$1.24M | 0.01% | 525 |
|
|
2019
Q1 | $4.37M | Buy |
15,978
+2,881
| +22% | +$717K | 0.01% | 566 |
|
|
2018
Q4 | $2.93M | Sell |
13,097
-1,517
| -10% | -$356K | 0.01% | 631 |
|
|
2018
Q3 | $3.57M | Sell |
14,614
-868
| -6% | -$200K | 0.01% | 539 |
|
|
2018
Q2 | $3.21M | Buy |
15,482
+419
| +3% | +$88.9K | 0.01% | 529 |
|
|
2018
Q1 | $3.11M | Buy |
15,063
+10,078
| +202% | +$2.12M | 0.01% | 509 |
|
|
2017
Q4 | $947K | Buy |
4,985
+65
| +1% | +$12.5K | ﹤0.01% | 613 |
|
|
2017
Q3 | $931K | Hold |
4,920
| – | – | 0.01% | 454 |
|
|
2017
Q2 | $858K | Hold |
4,920
| – | – | ﹤0.01% | 463 |
|
|
2017
Q1 | $756K | Hold |
4,920
| – | – | ﹤0.01% | 482 |
|
|
2016
Q4 | $694K | Sell |
4,920
-40
| -0.8% | -$5.9K | ﹤0.01% | 478 |
|
|
2016
Q3 | $789K | Sell |
4,960
-11,175
| -69% | -$1.72M | ﹤0.01% | 443 |
|
|
2016
Q2 | $2.38M | Buy |
16,135
+395
| +3% | +$58.3K | 0.01% | 406 |
|
|
2016
Q1 | $2.23M | Sell |
15,740
-44,409
| -74% | -$5.95M | 0.02% | 342 |
|
|
2015
Q4 | $8.53M | Sell |
60,149
-85,500
| -59% | -$11.4M | 0.05% | 260 |
|
|
2015
Q3 | $17.8M | Buy |
145,649
+28,818
| +25% | +$3.75M | 0.11% | 183 |
|
|
2015
Q2 | $15.2M | Sell |
116,831
-46,189
| -28% | -$6.02M | 0.08% | 213 |
|
|
2015
Q1 | $21.9M | Sell |
163,020
-28,887
| -15% | -$3.72M | 0.12% | 176 |
|
|
2014
Q4 | $24M | Buy |
191,907
+7,308
| +4% | +$889K | 0.12% | 158 |
|
|
2014
Q3 | $22.5M | Sell |
184,599
-14,357
| -7% | -$1.75M | 0.11% | 170 |
|
|
2014
Q2 | $23.5M | Sell |
198,956
-6,101
| -3% | -$718K | 0.11% | 172 |
|
|
2014
Q1 | $24.7M | Buy |
205,057
+500
| +0.2% | +$59.4K | 0.12% | 162 |
|
|
2013
Q4 | $22.8M | Sell |
204,557
-4,391
| -2% | -$437K | 0.12% | 175 |
|
|
2013
Q3 | $19.3M | Sell |
208,948
-1,696
| -0.8% | -$153K | 0.1% | 188 |
|
|
2013
Q2 | $17.8M | Buy |
+210,644
| New | +$17.5M | 0.09% | 202 |
|
Other funds holding TMO
VCM
Mackenzie Financial's TMO Position: Q1 2026 in Review
Mackenzie Financial reduced its Thermo Fisher Scientific (TMO) stake by 32% in Q1 2026, selling an estimated $58.1M and leaving 222,589 shares worth $109M. The position accounts for 0.13% of the portfolio, ranked #144.
Mackenzie Financial first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $659M in Q2 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Mackenzie Financial held 222,589 shares of Thermo Fisher Scientific worth $109M as of Q1 2026.
- Mackenzie Financial sold 107,077 Thermo Fisher Scientific shares in Q1 2026, an estimated $58.1M.
- Thermo Fisher Scientific made up 0.13% of Mackenzie Financial's portfolio in Q1 2026, its #144 holding.
- Mackenzie Financial first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Mackenzie Financial's Thermo Fisher Scientific position peaked at $659M in Q2 2023.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.